ArticleNutrients2021
Dietary Exposure and Risk Assessment of Aflatoxin M1 for Children Aged 1 to 9 Years Old in Serbia.
Article in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 35 citations in OpenAlex.
- Seasonal Variation and Health Risk Assessment of Aflatoxin M1 in Milk From the Central Region of Iran.Veterinary medicine and science · 2026Article
- Aflatoxin M1 in Milk from South-Central and Northwest China: Prevalence and Integrated Risk Characterization for Different Age-Sex Groups of Consumers.Foods (Basel, Switzerland) · 2026Article
- Occurrence and health risk assessment of AFM1 in commercial yogurt in Thailand.Mycotoxin research · 2026Article
- Climate-Driven Aflatoxin MToxins · 2026Review
- Aflatoxins and Human Health: Global Exposure, Disease Burden, and One Health Strategies.Toxins · 2026Review
- Aflatoxin M1 in Milk and Dairy Products in Birjand, Iran: A Contribution to Human Health Risk Assessment.Food science & nutrition · 2025Article
- Article
- Occurrence of Aflatoxin M1 over Three Years in Raw Milk from Croatia: Exposure Assessment and Risk Characterization in Consumers of Different Ages and Genders.Foods (Basel, Switzerland) · 2025Article
- Article
- Climate Change and Mycotoxins Trends in Serbia and Croatia: A 15-Year Review.Foods (Basel, Switzerland) · 2024Review
- Review of the Terminology, Approaches, and Formulations Used in the Guidelines on Quantitative Risk Assessment of Chemical Hazards in Food.Foods (Basel, Switzerland) · 2024Review
- Assessment of Human Health Risks from Aflatoxin M1 in Raw Milk: A Study from North Shewa Zone, Oromia Region, Ethiopia.Environmental health insights · 2024Article
- Article
- Aflatoxin Contamination: An Overview on Health Issues, Detection and Management Strategies.Toxins · 2023Review
- Article
- Article
- Probabilistic modeling and risk characterization of the chronic aflatoxin M1 exposure of Hungarian consumers.Frontiers in microbiology · 2022Article
- Implementation of Harmonized Food Consumption Data Collection in the Balkan Region According to the EFSA EU Menu Methodology Standards.Frontiers in nutrition · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
Abstract
The present study was conducted to estimate the exposure and characterize the risk for the child population of Serbia to Aflatoxin M1 (AFM1) from milk and milk-based food. A total of 3404 samples comprising milk and different milk-based food samples were collected from various regions of Serbia from 2017 to 2019. Evaluation of AFM1 exposure was carried out using the deterministic method, whereas risk characterization was evaluated using the margin of exposure (MOE) and the risk of hepatocellular carcinoma (HCC). Detection rates for AFM1 in milk and milk-based food samples ranged between 2% and 79%, with the highest incidence (79%) and mean level (22.34 ± 0.018 ng kg
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.